- Global Pharma News & Resources

IATI Appoints New Co-Chair and Board of Directors

IATI, Israel's umbrella organization of high-tech and life sciences industries, which includes more than 700 organizations, including multinationals, mature Israeli companies, venture capital funds, university and hospital commercialization bodies, incubators and life science companies, Academics, municipalities and local authorities, elected this week a new Board of Directors and a new Chairperson.

Erez Zur, Chairman of Infibond who will continue in his position, and Yaacov Michlin, CEO of Brainsway, were chosen to serve as co-chairpersons of the union, alongside IATI's CEO and President, Karin Meir Rubinstein. Michlin, who represents the life sciences sector, will replace Yaki Yanai, who has completed a three-year term.

The new Board of Directors consists of 29 key people, 50% of whom are new, representing all sectors and dimensions of the industry: Prof. Yossi Matias (Google), Tomer Bar Zeev (IronSoource), Gil Golan (General Motors), Yuval Tal (Payoneer), Shahar Bar Or (Western Digital), Rafi Margaliot (Micro Focus), Yahal Zilka (Magma Fund), Jonathan Medved (OurCrowd), Dr. Yair Schindel (aMoon Fund), Yoram Oron (Vertex), Eyal Niv (Pitango), Dr. Efrat Shefer (Philips), Tal Levy (Bio-technology General), Dan Glotter (Optimal Plus), Imad Talhami (Babcom), Racheli Ganot (Rachip), Alon Aginsky (BlockchainIL), Miriam Shtilman-Lavsovski (Algotec Systems), Itzik Frid (Takwin Labs), Yonatan Adiri (, Anat Cohen-Dayag (Compugen), Dr. Eran Eden (MeMed), Prof. Varda Shalev (Maccabi Tech), Nadav Kidron (Oramed), Elka Nir (Carevature), Yaki Yanai (Pluristem), Jonatan Berger (The Kitchen), Shlomo Nimrodi (Ramot), Yoram Tietz (Ernst & Young).

Click for the full list of IATI Board:

Karin Meir Rubinstein, IATI CEO and President: "I would like to thank the previous Board of Directors for their contribution to advancing the high-tech and life sciences industry in Israel, and to congratulate the new elected Board of Directors. It is a strong board which reflects all parts of the industry, and all the relevant fields of innovation today, including Digital Health, BlockChain and Crypto, and more".

"As the innovative industries play a more significant role in Israel's economy, we face many more challenges. The growth in demand for skilled workers requires intensive cooperation with regulators and academia in order to prepare both in the short and long term. Human resources are Israel's main resource, and we must continue to work to create and expand programs to integrate various populations - ultra-Orthodox, Arab and women - and to allow wider entry into the periphery".

IATI is the umbrella organization for the hi-tech, life sciences and other advanced industries in Israel, with hundreds of members paying from all corners of the industry. IATI connects the technological ecosystem in Israel, provides solutions and support at various levels, and integrates the various sectors in the industry for common strategic and government objectives.

As the umbrella organization of the innovative industries, IATI cooperates with the relevant public and private organizations in Israel whose goal is to promote the high-tech and life sciences industry in Israel. IATI is the most prominent and important representative of the Israeli high-tech industry vis-a-vis policymakers in the government, authorities and academia. The Association also provides its members with a wide range of services, including business development and the creation of business opportunities, professional seminars and events, statistical reports, government support and promoting legislation.

View source version on

Editor Details

  • Company:
    • Business Wire
  • Website:
Last Updated: 28-Oct-2018